Adipose‐derived stem cells (ASCs) are a mesenchymal stem cell source with properties of
self‐renewal and multipotential differentiation. Compared to bone marrow‐derived stem …

Wound healing is a complex but a fine‐tuned biological process in which human skin has
the ability to regenerate itself following damage. However, in particular conditions such as …

Background Adipose-derived stem cells (ASCs) have been introduced as an alternative to
bone marrow mesenchymal stem cells (BMSCs) for cell-based therapy. However, different …

Mesenchymal stem/stromal cells (MSCs) are promising cell sources for regenerative
therapies due to their multipotency and ready availability, but their application can be …

MSCs products as well as their derived extracellular vesicles, are currently being explored
as advanced biologics in cell-based therapies with high expectations for their clinical use in …

Bone tissue engineering (BTE) is now a promising research issue to improve the drawbacks
from traditional bone grafting procedure such as limited donor sources and possible …

Adipose-derived stromal/stem cells (ASCs) seems to be a promising regenerative
therapeutic agent due to the minimally invasive approach of their harvest and multi-lineage …

Bone nonunion is a pathological condition in which all bone healing processes have
stopped, resulting in abnormal mobility between 2 bone segments. The incidence of bone …

Advanced age is associated with an increased risk of vascular morbidity, attributable in part
to impairments in new blood vessel formation. Mesenchymal stem cells (MSCs) have …

Worldwide, hard-to-heal lower limb wounds are estimated to affect 1.5–3% of the adult
population with a treatment-related annual cost of $10 billion. Thus, chronic skin ulcers of …